ABT-384

ABT-384 · Abbott

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ABT-384, covering 2010-11-03 to 2013-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease [Phase 2]